Overview

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources.
Phase:
Phase 2
Details
Lead Sponsor:
Gillette Children's Specialty Healthcare
Scott Schwantes, M.D.
Treatments:
Gabapentin
gamma-Aminobutyric Acid